Regulating Bioprospecting: Institutions for Drug Research, Access and Benefit Sharing

Note moyenne 5
( 1 avis fournis par Goodreads )
 
9789280811124: Regulating Bioprospecting: Institutions for Drug Research, Access and Benefit Sharing


Bioprospecting—the search for useful biochemical compounds and genes in nature—has been the focus of international negotiations for more than a decade. The debate on the terms for access to genetic resources, traditional knowledge, and benefit-sharing is far from settled. This book examines the optimal property rights structures and institutional mechanisms for regulating bioprospecting for drug research. It includes examples of bioprospecting collaborations in several countries. Regulating Bioprospecting is one of the first books to address the contractual complexities of bioprospecting for drug research and is thus a key text for policymakers, practitioners, and scholars in the areas of law, economics, ethnobotany, anthropology, and environmental sciences. "The book offers stimulating insights in a rigorous and accessible manner. It will be of great value for researchers, policymakers, managers, and all those concerned with the protection and sustainable use of biodiversity."—Carlos M. Correa, University of Buenos Aires, Argentina "A welcome contribution to an important but highly polarized debate."—Graham Dutfield, Queen Mary Intellectual Property Research Institute, University of London, UK


Les informations fournies dans la section « Synopsis » peuvent faire référence à une autre édition de ce titre.

About the Author :

Padmashree Gehl Sampath is a researcher at the United Nations University Institute for New Technologies (UNU-INTECH). She has consulted for the WHO Commission on Intellectual Property, Innovation and Health, UNCTAD, the European Commission, and the German Government.

Review :

"This book is a significant contribution to the literature and will stimulate valuable discourse." —Daniel B. Magraw, Centre for International Environmental Law, Washington, USA



"The author examines, with outstanding analytical capabilities, complex economic issues of particular importance to developing countries and the drug industry. The book offers stimulating insights in a rigorous and accessible manner. It will be of great value for researchers, policy makers, managers, and all those concerned with the protection and sustainable use of biodiversity." —Carlos M. Correa, University of Buenos Aires, Argentina



"An excellent and comprehensive overview of the many complex facets of the bioprospecting and drug discovery and development process, and an invaluable source of information and guidance to those seeking to establish programs and agreements built on foundations of reasonable access and equitable benefit-sharing." —Gordon Cragg, Former Director, Natural Products Branch, National Cancer Institute, USA



"A welcome contribution to an important but highly polarized debate. It offers an objective and academically rigorous treatment of what is a highly complex subject, and in doing so should contribute to fairer and more effective bioprospecting regulation." —Graham Dutfield, Queen Mary Intellectual Property Research Institute, University of London, UK

Les informations fournies dans la section « A propos du livre » peuvent faire référence à une autre édition de ce titre.

Acheter neuf Afficher le livre
EUR 89,59

Autre devise

Frais de port : Gratuit
Vers Etats-Unis

Destinations, frais et délais

Ajouter au panier

Meilleurs résultats de recherche sur AbeBooks

1.

Padmashree Gehl Sampath
Edité par United Nations University Press (2005)
ISBN 10 : 9280811126 ISBN 13 : 9789280811124
Neuf(s) Paperback Quantité : 1
Vendeur
Irish Booksellers
(Rumford, ME, Etats-Unis)
Evaluation vendeur
[?]

Description du livre United Nations University Press, 2005. Paperback. État : New. book. N° de réf. du libraire M9280811126

Plus d'informations sur ce vendeur | Poser une question au libraire

Acheter neuf
EUR 89,59
Autre devise

Ajouter au panier

Frais de port : Gratuit
Vers Etats-Unis
Destinations, frais et délais